BioXcel Therapeutics, Inc. (BTAI) has 38 open-market insider trades by 8 insiders since 2018. The most active filer is Vimal Mehta, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Vimal Mehta | CEOPres | — | 11 | $31.6M | 2026-06-15 |
| Krishnan Nandabalan | Dir10% Owner | — | 4 | $31.4M | 2023-04-06 |
| BioXcel Holdings, Inc. | CEOPres10% Owner | — | 2 | $15.4M | 2024-06-05 |
| BioXcel LLC | 10% Owner | — | 1 | $14.6M | 2021-06-25 |
| Vincent O'Neill | — | — | 4 | $4.8M | 2024-12-16 |
| Frank Yocca | CSO | — | 8 | $3.8M | 2026-06-15 |
| Peter Mueller | Dir | — | 4 | $212K | 2019-08-23 |
| Richard I. Steinhart | CFO | — | 4 | $188K | 2026-06-15 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Vimal Mehta | CEO & President | Sell | $21K | 2026-05-20 |
| Richard I. Steinhart | CFO | Sell | $7K | 2026-05-20 |
| Javier Rodriguez | — | Sell | $7K | 2026-05-20 |
| Frank Yocca | Chief Scientific Officer | Sell | $153 | 2024-12-16 |
| Vimal Mehta | President & 10% | Sell | $1K | 2024-12-16 |
| Richard I. Steinhart | CFO | Sell | $208 | 2024-12-16 |
Companies that share insiders with BTAI, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Vincent O'Neill | — | Sell | $58 | 2024-12-16 |
| Richard I. Steinhart | CFO | Sell | $4K | 2024-10-03 |
| Javier Rodriguez | — | Sell | $4K | 2024-10-03 |
| Vincent O'Neill | — | Sell | $3K | 2024-10-03 |
| Matthew T. Wiley | Chief Commercial Officer | Sell | $3K | 2024-10-03 |
| Vimal Mehta | President & 10% | Sell | $1K | 2024-09-16 |
| Richard I. Steinhart | CFO | Sell | $246 | 2024-09-16 |
| Frank Yocca | Chief Scientific Officer | Sell | $245 | 2024-09-16 |
| Javier Rodriguez | — | Sell | $238 | 2024-09-16 |